BridgeMD
Compares treatment options for Myoma;Uterus
Official title Reducing Blood Loss During Myomectomy:Uterine Artery Ligation Vs Pericervical Tourniquet
ClinicalTrials.gov ID: NCT07526311
What this study is testing
- What it's testing
- The goal of this clinical trial is to compare two surgical techniques for reducing blood loss during transabdominal myomectomy in women with symptomatic uterine fibroids. The main question it aims to answer is whether bilateral uterine artery ligation reduces intraoperative blood loss more effectively than pericervical mechanical tourniquet application, without increasing operative complications.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 25 to 48, women only
You may be able to join if
- Female participants aged 25 to 48 years
- Body mass index less than 35 kg/m²
- Symptomatic uterine myomas requiring surgical treatment
- Intramural myomas classified as FIGO types 3 to 6
- Diagnosis confirmed by transvaginal ultrasound and/or magnetic resonance imaging
You likely can't join if
- Submucosal, intracavitary, pedunculated subserosal, cervical, or adnexal myomas
- FIGO types 0, 1, 2, 7, or 8 myomas
- History of pelvic inflammatory disease or peritonitis
- Previous abdominal or pelvic surgery for non-obstetric causes
- Previous uterine surgery
- Use of hormonal therapy within the previous 3 months
See the full eligibility criteria
- Female participants aged 25 to 48 years
- Body mass index less than 35 kg/m²
- Symptomatic uterine myomas requiring surgical treatment
- Intramural myomas classified as FIGO types 3 to 6
- Diagnosis confirmed by transvaginal ultrasound and/or magnetic resonance imaging
- Maximum diameter of the largest myoma 20 cm or less
- Scheduled for elective transabdominal myomectomy
- Able and willing to provide written informed consent
- Submucosal, intracavitary, pedunculated subserosal, cervical, or adnexal myomas
- FIGO types 0, 1, 2, 7, or 8 myomas
- History of pelvic inflammatory disease or peritonitis
- Previous abdominal or pelvic surgery for non-obstetric causes
- Previous uterine surgery
- Use of hormonal therapy within the previous 3 months
- Known bleeding disorder
- Use of anticoagulant or antiplatelet therapy
- Preoperative hemoglobin less than 10 g/dL
- Body mass index 35 kg/m² or greater
- Intraoperative conversion from myomectomy to hysterectomy
The study team makes the final eligibility decision.
Where it's taking place
- Cairo, Al-Manial, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 25 years to 48 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Cairo, Al-Manial, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.